Companies / Maze Therapeutics, Inc.
Maze Therapeutics, Inc.
Nasdaq: MAZECIK 1842295SOUTH SAN FRANCISCO, CA
Financials · FY2025
Ownership
55.5M shares outstanding · as of Aug 5, 2026
Ownership
| Insiders | 0.10% | 54,581 |
| Institutions | 91.53% | 50,843,931 |
| Public float | 8.37% | 4,650,656 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 12
View all →| Insider | % of shares | Shares |
|---|---|---|
Homcy Charles JDirector | 0.06% | 31,113 |
Bachrodt AmySVP, Finance | 0.02% | 12,965 |
Dandekar AtulCSBO | 0.02% | 10,503 |
Bernstein HaroldPresident, R&D & CMO | 0.00% | 0 |
Sohn Catherine A.Director | 0.00% | 0 |
Coloma Jason VCEOChief Executive Officer · Director | — | — |
Courtney PhillipsGC and Corp. Secretary | — | — |
Kumar NeilDirector | — | — |
Lim Jonathan EDirector | — | — |
Scheller Richard HDirector | — | — |
Institutional holders 156
View all →| Holder | Value | % of shares |
|---|---|---|
| $189.22M | 8.22% | |
| $185.36M | 8.05% | |
| $175.93M | 7.64% | |
| $122.98M | 7.42% | |
| $104.52M | 6.31% | |
| $85.28M | 5.15% | |
| $70.52M | 3.06% | |
| $70.31M | 3.05% | |
| $64.16M | 2.79% | |
| $42.92M | 1.86% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $36.28M | +1.2M +53.15% | 3,502,841 6.31% of shares | medium |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | New | — | $35.16M | +1.2M | 1,178,000 2.12% of shares | medium |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Trim | — | $-16.02M | -537K -63.35% | 310,639 0.56% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $13.86M | +465K +87.15% | 997,533 1.80% of shares | medium |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Trim | — | $-8.46M | -284K -9.03% | 2,858,876 5.15% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | Add | — | $7.82M | +262K +131.49% | 461,151 0.83% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | — | $-3.72M | -125K -80.65% | 29,892 0.05% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | — | $2.17M | +73K +13.79% | 599,967 1.08% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Third Rock Ventures IV, L.P. | Passive13G/A | — |
| Gv 2019, L.P. | Passive13G/A | — |
| Frazier Life Sciences Public Fund, L.P. | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| MAZE | — | 578784100 |